CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER). The gene discussed is CD19; the disease is B-cell non-Hodgkin lymphoma.